1-5 of 5
Laura Carrassa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas

Free
Roberta Frapolli, Ezia Bello, Marianna Ponzo, Ilaria Craparotta, Laura Mannarino, Sara Ballabio, Sergio Marchini, Laura Carrassa, Paolo Ubezio, Luca Porcu, Silvia Brich, Roberta Sanfilippo, Paolo Giovanni Casali, Alessandro Gronchi, Silvana Pilotti, Maurizio D'Incalci
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (5): 1199.
https://doi.org/10.1158/1078-0432.CCR-20-0172
Published: 02 March 2020
View articletitled, Correction: Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas
Open the PDF for Correction: Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas in another window
Journal Articles

Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas

Free
Roberta Frapolli, Ezia Bello, Marianna Ponzo, Ilaria Craparotta, Laura Mannarino, Sara Ballabio, Sergio Marchini, Laura Carrassa, Paolo Ubezio, Luca Porcu, Silvia Brich, Roberta Sanfilippo, Paolo Giovanni Casali, Alessandro Gronchi, Silvana Pilotti, Maurizio D'Incalci
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (24): 7565–7575.
https://doi.org/10.1158/1078-0432.CCR-19-0976
Published: 13 December 2019
View articletitled, Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas
Open the PDF for Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas in another window
Includes: Supplementary data
Journal Articles

The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

Free
Filippo Spriano, Elaine Yee Lin Chung, Eugenio Gaudio, Chiara Tarantelli, Luciano Cascione, Sara Napoli, Katti Jessen, Laura Carrassa, Valdemar Priebe, Giulio Sartori, Garrett Graham, Saravana P. Selvanathan, Andrea Cavalli, Andrea Rinaldi, Ivo Kwee, Monica Testoni, Davide Genini, B. Hilda Ye, Emanuele Zucca, Anastasios Stathis, Brian Lannutti, Jeffrey A. Toretsky, Francesco Bertoni
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (16): 5167–5176.
https://doi.org/10.1158/1078-0432.CCR-18-2718
Published: 15 August 2019
View articletitled, The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents
Open the PDF for The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents in another window
Includes: Supplementary data
Journal Articles

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy

Free
Chiara Tarantelli, Eugenio Gaudio, Alberto J. Arribas, Ivo Kwee, Petra Hillmann, Andrea Rinaldi, Luciano Cascione, Filippo Spriano, Elena Bernasconi, Francesca Guidetti, Laura Carrassa, Roberta Bordone Pittau, Florent Beaufils, Reto Ritschard, Denise Rageot, Alexander Sele, Barbara Dossena, Francesca Maria Rossi, Antonella Zucchetto, Monica Taborelli, Valter Gattei, Davide Rossi, Anastasios Stathis, Georg Stussi, Massimo Broggini, Matthias P. Wymann, Andreas Wicki, Emanuele Zucca, Vladimir Cmiljanovic, Doriano Fabbro, Francesco Bertoni
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (1): 120–129.
https://doi.org/10.1158/1078-0432.CCR-17-1041
Published: 02 January 2018
View articletitled, PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy
Open the PDF for PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy in another window
Includes: Supplementary data
Journal Articles

Checkpoint Kinase 1 Down-Regulation by an Inducible Small Interfering RNA Expression System Sensitized In vivo Tumors to Treatment with 5-Fluorouracil

Free
Monica Ganzinelli, Laura Carrassa, Francesca Crippa, Michele Tavecchio, Massimo Broggini, Giovanna Damia
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5131–5141.
https://doi.org/10.1158/1078-0432.CCR-08-0304
Published: 12 August 2008
View articletitled, Checkpoint Kinase 1 Down-Regulation by an Inducible Small Interfering RNA Expression System Sensitized In vivo Tumors to Treatment with 5-Fluorouracil
Open the PDF for Checkpoint Kinase 1 Down-Regulation by an Inducible Small Interfering RNA Expression System Sensitized In vivo Tumors to Treatment with 5-Fluorouracil in another window